Stocks
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Debt/EBITDA | -0.01 | -0.41 | -0.96 | -23.4 | -5.26 | -4.71 | ||
| Changes by years, y/y, % | -101% | +4 521% | +133% | +2 351% | -78% | |||
Heron Therapeutics. Debt/EBITDA
Heron Therapeutics. Debt/EBITDA, changes, %
Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 45.9 | 20.0 | -25.7 | -7.32 | -4.01 | -4.71 | ||
| Changes by years, y/y, % | -3 321% | -814% | +363% | -69% | -109% | |||
| Changes by quarters, q/q, % | -296% | -56% | -228% | -71% | -45% | |||
